chrisvoncsefalvay/vaers-outcomes huggingface dataset:
became covid positive; This spontaneous case was reported by a nurse and describes the occurrence of COVID-19 (became covid positive) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced COVID-19 (became covid positive). At the time of the report, COVID-19 (became covid positive) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.  No concomitant medication was provided.
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Healthcare consulted with the Dept of Public Health and Environment and did not recommend repeating this dose in question. No ill effect post administration was reported.
Started as a radiating pain to finger tips and into left chest (felt like a heart attack) night one, a few hours after vaccination a bright red circle appeared about an inch in diameter and continued for 72 hours, the turned purple for the next few days. 7 days later spot on arm is purple/red, raised and itchy. comparable to a bug bite
On that Saturday morning 11/6/2021, I woke up and at some point, I noticed that the 3 middle toes on my right foot were turning black where they meet the foot. Not at the tip of the toes, but where the toes meet the foot. They turned black and there was no pain. I didn't do anything right away, but I noticed by Sunday night that the blackness was going away, and it was fading to a purple. On Monday, I saw doctor to see what was going on. I don't believe I injured my foot, and I don't remember doing anything like that. We did a blood test and, on that Wednesday, I did an ultrasound and an echocardiogram and abdominal scan and doppler ultrasound of the legs to see the circulatory system to see if that would explain the discoloration. All results came back fine. I noticed by the end of last Friday, all of the discoloration was basically gone. I noticed today that it's totally gone. So, we never figured out why it happened. All I know is that it's done with now.
Within 15 minutes of getting the shot my throat began to swell and it was made hard to breathe. I had issues with speech and thought. I spent 5 total days in the hospital where I received a CT Scan and MRI along with numerous blood tests. I had impaired speech and motor skills.  I now struggle with my memory and I have no emotional reaction to events.
Site of injection red, swollen, itchy, 7.5cm erythema, induration warm to touch.
Tinnitus; This is a spontaneous report from a contactable nurse, the patient. A 50-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 06Jan2021 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. The medical history was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive other vaccines within four weeks prior to the vaccination. The patient did not receive any medications within two weeks of vaccination. On an unspecified date in 2021, the patient experienced tinnitus. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event tinnitus was unknown at the time of this report.    No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Patient was ordered to receive Polio, Varicella & Influenza vaccines. A dose of MMR was inadventently administered along with ordered vaccines. Mother notified immediately.
2 day post vaccine right arm is red, swollen, hot and itching. Site was initially painful on day 1. Also night of vaccine had generalized itching which was relieved with benadyrl.
This case was reported by a healthcare professional and described the occurrence of extensive swelling of vaccinated limb in a 28-year-old female subject who was vaccinated with BOOSTRIX (GlaxoSmithKline). Concurrent medications included Prednisone and VYVANSE. On 27 August 2014, the subject received a dose of BOOSTRIX (route unknown, left arm). On 27 August 2014, 30 minutes after vaccination with BOOSTRIX, the subject's entire arm was red, hot and swollen. This extended across the upper back and over to the right arm. No tightness in throat or trouble breathing. It was confined to both upper arms and upper back. The healthcare professional considered the events were clinically significant (or requiring intervention). The subject was treated with BENADRYL and ZYRTEC. On 28 August 2014, the events were resolved. The healthcare professional considered the events were probably related to vaccination with BOOSTRIX.
Approximately 46 hours after my 2nd shot, I started to become dizzy. My blood pressure rose to 161/96. From 4/14/2021 through 4/25 /2021I experienced dizziness and nauseous effects to the point of feel like I was gagging. However, I would feel better if I sat perfectly still. When I would get up and start to move around the house, the symptoms resumed. It seemed to mimic motion sickness.
Hospitalization for Severe sepsis due to UTI, incidental COVID-19 on dates  9/7/22-9/12/22. Treated with no COVID-19 medications.
Employee reported that she began dry, burning lips and neck which started day after covid vaccine administered. On day 2 following vaccine, employee reported lips began to swell and rash and hives developed on neck and chest.  Lip swelling resolved on 1/31/2021 and employee still has rash on chest and neck, but is improving.  Employee was using Benadryl cream for rash and itching and was also taking Benadryl orally 50 mg at bedtime and was taking Claritin during day.  Did not have to seek emergency treatment but did miss 1 day of scheduled work.  Employee is also reporting fatigue and pain in joints. Has a hx of lupus and RA and believes vaccine may have caused a flare.
This spontaneous report was received from a licensed practical nurse, referring to a 19 year old, female patient. The patient's medical history, concurrent conditions and drug reactions/allergies were not reported. On unknown dates, the patient was vaccinated with the three dose series of GARDASIL (dose, route, lot # and expiration date were not reported). Then, on 11-AUG-2015, the patient was vaccinated with an additional dose of GARDASIL 9 by intramuscular route in the left arm (reported as LD), lot # K026247 (expiration date was not reported), because a company representative mistakenly told that it was the Centers for Disease Control and Prevention (CDC) recommendation. No concomitant medications were reported. No adverse effects were reported. No product quality complaint was involved. This is one of several reports received from the same source. Additional information is not expected as all scheduled follow up information has been received.
Stiff muscles in my neck, tolerable arm pain in the injection arm. Flushed feeling face, unproductive sleep, tension in the muscles on the back and top of my head. Fatigue. It's not life threatening, just uncomfortable, but I absolutely understand the importance of data, so here you go XD. Really it's the sore muscles in my neck and head that are the most curious. I get a flu shot every year and this is the first time I've experienced this. Kind of like the top of my head is throbbing. I take generic Zyrtec (Costco, aller-tec) and a multi-vitamin.
6 hours after receiving 1st dose i developed pressure and pain in my chest.i had trouble taking in a breath.very uncomfortable.spent 12 hours in the er.was told i had a reaction to the vaccine.
This case was reported by a pharmacist via call center representative and described the occurrence of chills in a 69-year-old male patient who received SHINGRIX (batch number 9AS39, expiry date 13th July 2020). On 8th May 2018 17:35, the patient received the 1st dose of SHINGRIX (intramuscular). In May 2018, less than a week after receiving SHINGRIX, the patient experienced chills, influenza-like symptoms and pain. The patient was treated with TYLENOL. On an unknown date, the outcome of the chills, influenza-like symptoms and pain were unknown. The reporter considered the chills, influenza-like symptoms and pain to be almost certainly related to SHINGRIX. Additional details were provided as follows: No concomitant vaccines were administered at the time of reporting. The patient received SHINGRIX in the left deltoid. The patient experienced achiness. The healthcare professionals (HCP) was informed about the adverse events the day after administration (around lunch). The HCP was unsure when the patient developed the events and whether the events are resolved or not. The HCP believed the symptoms were almost certainly or probably related to the SHINGRIX.
Patient experienced chest pain and tachycardia after covid 19 moderna #2 vaccine on 5/22/21. pt had temp 100.4 after vaccine and the following night had left chest pressure and palpitations so he went to the ER. Pt had nl labs, ECG- sinus tachy, right axis deviation , nl cxr and neg- covid 19 test. pt palpitations and pain resolved while in ER. Pt had second episode of chest pain on night of 5/24/21 but did not go to ER
MRI brain showed large ischemic stroke involving brainstem, bilateral cerebellum, occipital and thalamic region due to basilar artery occlusion.
Caller received his first vaccine on 4/23/21.  Noted on yesterday a pea size nodule on his right collar bone which is the the arm he received his injection.  Denies pain, swelling or redness, only feels it, not able to see it.  Instructed to apply warm compresses, observe for signs of swelling or increase in size and to notify his MD if these changes occur.
Hives; Rash; This case was reported by a pharmacist via call center representative and described the occurrence of generalized urticaria in a 79-year-old male patient who received Herpes zoster (Shingrix) (batch number E927Z, expiry date 27th February 2021) for prophylaxis.   On 29th August 2018, the patient received the 2nd dose of Shingrix. On an unknown date, less than a year after receiving Shingrix, the patient experienced generalized urticaria and rash. The patient was treated with prednisone. On an unknown date, the outcome of the generalized urticaria and rash were not recovered/not resolved.   It was unknown if the reporter considered the generalized urticaria and rash to be related to Shingrix.  Additional details were provided as follows: The patient had generalized hives after vaccination of Shingrix and breakouts since the administration. The patient had no problem until administration of 2nd dose of Shingrix. The patient stated that, the hives gone, when the patient taken prednisone, but still had reoccurence of symptoms.
Patient stated feeling lightheaded and palpitations Patient provided with food and water, stated symptoms resolved Patient seen by medical team, refused medical transport and signed AMA form
nose keeps running; 100.2 degrees F fever; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (nose keeps running) and PYREXIA (100.2 degrees F fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In November 2021, the patient experienced RHINORRHOEA (nose keeps running) and PYREXIA (100.2 degrees F fever). At the time of the report, RHINORRHOEA (nose keeps running) and PYREXIA (100.2 degrees F fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In November 2021, Body temperature: 100.2 (High) 100.2 degrees F fever.         No concomitant medication were reported. No treatment information was provided by the reporter.
TINGLING FROM THE INJECTION SITE RADIATING DOWN TO THE ELBOW HAPPENING INTERMITTENTLY FROM 10/8/19 AND CONTINUING THROUGH THE TIME OF REPORTING THE EVENT (12/17/19)
pt recvd vax;mom reports approx 1 1/2 hrs after vax,pt began screaming, v,became pale & lifeless; mom contacted PMD who advised to call hlth dept; mom took pt to er; pt better, more responsive on arrival at er;
Extreme vertigo 15 hours post injection. Cleared by 19 hours.; This is a spontaneous report from a contactable consumer (patient). A 74-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, lot no and expiry dates were not reported) via unspecified route of administration on 01Feb2021 at 11:45 AM in left arm as single dose for covid-19 immunisation. Medical history included allergies to penicillin and cholesterol. At the time of vaccination, she had not been pregnant. Concomitant medication included rosuvastatin, cyanocobalamin (VIT B12), ergocalciferol (VIT D), iron, zinc, ascorbic acid (VIT C). Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced extreme vertigo 15 hours post injection on 02Feb2021 at 03:00 AM and cleared by 19 hours. She did not receive treatment for the adverse event. No COVID Ppior to vaccination. It was also reported that since the vaccine, the patient had not been tested for COVID-19. The outcome of event was recovered.  Information on the lot/batch number has been requested.
Did not have full control of ''my'' right hand. It has been three days now and ''I'' still have lost partial control of ''my'' hand./ almost no control in ''my'' fingers especially ''my'' pinky.; Would almost describe it as a muscle spasm or a cramp; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN5318) via an unspecified route of administration in the right arm on 05Mar2021 at 16:00 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not take any concomitant medications. On 06Mar2021 at 12:00, the patient woke up Saturday morning, the day after getting the first vaccine shot and did not have full control of his right hand. It had been three days at the time of this report and still had lost partial control of hand, almost described it as a muscle spasm or a cramp. Whenever opened the hand could see that physically the hand was not right, it was almost as if there was no muscle on the side of the hand. The patient could make a fist but could not open hand and make fingers touch each other. The patient almost not had control in fingers especially his pinky. The patient was worried and needed to be contacted as soon as possible. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events did not have full control of his right hand, it had been three days and still had lost partial control of his hand and would almost describe it as a muscle spasm or a cramp was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
12/6 Moderna Booster Shot 12/7 slight muscle aches and chills which ended around 10pm 12/8 woke up with swollen lips on the left side of my mouth and tingling sensation in the left side of my face
high pitched screaming x 2 hrs (12 hrs post vax) intermittently consolable;
COVID19 Breakthrough case. History: on 8/22/21 Patient arrived to HCF on 8/17 with cough, fever, & generalized fatigue x 2 days. Tested positive for COVID-19 on 8/17. Admitted on room air but worsening respiratory status & bilateral pulmonary infiltrates. Oxygen requirements escalated to 60% on CPAP & 8/24 pt was transferred here for further management. He received convalescent plasma on 8/18. Remdesivir started 8/23. Transferred from outside facility on 8/24/21. Diagnosed with acute hypoxic respiratory failure secondary to Covid-19 pneumonia. Remains hospitalized as 9/9/21 (day of report submission). Please note: Patient received first dose Pfizer vaccine on 3/28/2021 Lot # EP6955 and the second dose on 4/18/2021 Lot # ER873
Case number PHEH2016US021760, is an initial spontaneous report received from a health care professional on 23 Aug 2016. This report refers to a 21-year-old female patient. Medical history was not reported. Concomitant medication was not reported. The patient was vaccinated with one single dose FLUVIRIN (batch number: 1619901, expiry date not reported) at a dose of 0.5 ml intramuscularly on 15 Aug 2016.No adverse event was reported following this maladministration (Incorrect product storage).
Patient given Moderna  Covid Vaccine at age 17 years 10.5 months.  Did not have any reaction at this time.
TACHYCARDIA; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (TACHYCARDIA) in an adult male patient who received mRNA-1273 (COVID 19 Vaccine Moderna) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Rheumatoid arthritis.    Concurrent medical conditions included Rheumatoid arthritis.   On 18-Aug-2018, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) 40 milligram every two weeks. In May 2021, the patient received first dose of mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular) 1 dosage form. In June 2021, received second dose of mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular) dosage was changed to 1 dosage form. In February 2022, received third dose of mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular) dosage was changed to 1 dosage form. In February 2022, the patient experienced TACHYCARDIA (TACHYCARDIA). At the time of the report, TACHYCARDIA (TACHYCARDIA) had resolved.            It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  No concomitant product use was reported.  In March-2022, the patient had another episode of Tachycardia which was recovered on an unknown date.  No treatment information was provided.  The reporter's causality for the events of tachycardia onset in February-2022, tachycardia onset in March-2022 Humira 40MG/0.8ML (Adalimumab) was no reasonable possibility.   This case was linked to MOD-2022-636538.
Had both shots and have had them/Suspected vaccination failure; Have had them about 5 times; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.     Additional Information: GSK Receipt Date: 20-SEP-2022 Reporter's Comment: This case was reported by a patient via interactive digital media The reporter reported that the patient received Shingles vaccine. The reporter stated that after received Shingrix vaccine the patient experienced shingles 5 times. The reporter stated that the vaccines are not 100 percentage effective in his case. Additional supportive information: This case was considered as suspected vaccination failure as details regarding time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
Woke up with feelings of "electric jolts" to right side of face, neck and down both arms. Accompanied by dizziness and loss of motor function (both legs and arms/hands).  Loss of balance and inability to walk properly.  More back and neck pain weakness and nausea.  Discomfort in spine.  Feelings of loss in urinary control.
Patient was 16 at time of J&J covid vaccination given, Mother notified immediately.  No adverse reaction occurred.
Pain in limbs, arms, hands, legs knees, wrists and forearms; Pain in limbs, arms, hands, legs knees, wrists and forearms; This is a spontaneous report from a contactable consumer (patient). A 67-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, Batch/Lot number and expiry date were not reported), via an unspecified route of administration, administered in right arm on 19May2021 15:00 (at the age of 67 years old) as dose 1, single for covid-19 immunization. Medical history included known allergies to "Milo gram dye" (as reported). The patient had no covid prior vaccination. The patient's concomitant medications were not reported. The patient previously took atorvastatin calcium (LIPITOR; reported as lipatour) and experienced allergy (also reported as known allergies).   The patient had no other vaccine in four weeks. The most recent COVID-19 vaccine was administered in a public health clinic. On 24May2021, the patient experienced pain in limbs, arms, hands, legs knees, wrists and forearms. The adverse events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the reported events which included increased dosage of prednisone 5mg to 7mg. The patient was not tested for covid post vaccination. The events were reported as medically significant. The outcome of the events was not recovered.   Information on the batch/lot has been requested.
PATIENT RECIVED 1ST DOSE OF MODERNA VACCINE, HE WAS SENT TO SIT DOWN FOR 15 MINUTES AFTER VACCINES.  AFTER 5 MINUTES SITTING, THE PATIENT STARTED TO SEIZING IN THE CHAIR.  THE SEIZURE LASTED LESS THAN 1 MINUTE AND HE BECAME CONCISOUS AGAIN.
Felt soreness, then chills, then nausea and dizziness. Started feeling weak and shaky and then eventually migraine. Still feeling side effects
Low immunoglobulin levels and little cuts that get infected and start of urinary tract infection. My health is getting worse and worse and there seems to be no viable cure as antibiotics cause a slew of other bacterial health issues in the body
Initial flu like symptoms, continuing fatigue, pain in joints. Two months later, pleurisy symptoms, treated for pneumonia. In June, ER visit, pain on inspiration the same. In July, ER visit, same. Cat scan revealed pericarditis. Pericardial window performed. Post hospital discontinued Mesalamine which was also contributing to systemic inflammation.   As of today, joint pain and extreme fatigue and weakness continue.   GI Doctor calls this a "confounding event" as both the vaccine and Mesalamine could have worked together, but the cascade of effects started with the second vaccine.
patient was given pfizer vacccine by health department on 2/24/22 and then we gave janssen to the patient on 2/25/22. On our consent form we ask the patient "Have you recieved another vaccine in the past 14 days" which the patient answered "No" to.